Publiziert in: Marktpuls, Unternehmen
Frei
Roche Investor Update: Reminder: Invitation to Roche's First Quarter Sales 2016 Conference Call Montag, 11. April 2016 - 15:01
| Basel, 11 April 2016 | |
 | |
| Roche will publish its Sales Results for the 1st Quarter of 2016 prior to the opening of the Swiss Stock Exchange on Tuesday April 19th, 2016. | ||||||||||
| 07:00 CEST / 06:00 BST / 01:00 AM EDT / 10:00 PM PDT (evening before) Release will be e-mailed and posted on the Roche IR website > click here. Presentation slides will be posted on the Roche IR website > click here. We would like to invite all interested parties to dial in as outlined below: 14:00 - 15:15 CEST / 13:00 - 14:15 BST 08:00 - 09:15 AM EDT / 05:00 - 06:15 AM PDT Conference call will start with presentations by senior management followed by a Q&A session (live access to the speakers). | ||||||||||
| ||||||||||
| To expedite the registration process on the day of the conference call, you may pre-register for the event> click here Alternatively you may dial in to the conference 10-15 min prior to the scheduled start , using the following numbers: +41 (0) 58 310 5000 (Europe and ROW)) +44 (0) 203 059 5862 (UK) +1 (1) 631 570 5613 (USA Toll Free) A live audio webcast can be accessed via > ir.roche.com. A replay of the webcast will be available via > ir.roche.com. | ||||||||||
| Best regards, |
| Karl Mahler Head of Investor Relations |
 | |
| Dr. Karl Mahler Phone: +41 61 68-78503 e-mail: karl.mahler@roche.com | Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com |
| Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com | Dr. Tamer Farhan Phone: +41 61 68-82552 e-mail: tamer.farhan@roche.com |
| Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com | |
 | |
| Nina Goworek Phone: +1 650 467-8737 e-mail: goworek.nina@gene.com | Ekaterine Kortkhonjia Ph.D. Phone: +1 650 467-5873 e-mail: kortkhonjia.ekaterine@gene.com |
11 April, 2016 Content owner:  Roche Investor Relations ©2016 F. Hoffmann-La Roche Ltd. |